Palbociclib Acetic Acid Adduct: Role in Pharmaceutical Impurity Analysis

In pharmaceutical development, identifying an impurity is often only the beginning of the analytical work. The more important question is whether the impurity can be reliably distinguished from the active pharmaceutical ingredient (API), accurately characterized, and monitored during manufacturing and stability studies. This becomes particularly relevant for complex molecules such as palbociclib, where process conditions, degradation pathways, and analytical sample preparation can all influence the impurity profile.

Palbociclib Acetic Acid Adduct is one of the compounds that can be encountered within the broader impurity profile associated with palbociclib. It is used as an analytical reference material to support the identification and monitoring of this specific component during pharmaceutical analysis.

Chemicea provides Palbociclib Acetic Acid Adduct as a pharmaceutical impurity reference standard for analytical and research applications.

Understanding Palbociclib Before Looking at Its Impurities

Palbociclib is a selective cyclin-dependent kinase 4/6 (CDK4/6) inhibitor. The FDA identifies its molecular formula as C24H29N7O2 and molecular weight as 447.54 Da. Its chemical structure contains several nitrogen-containing heterocyclic features, a cyclopentyl group, and a piperazine-containing side chain.

From an analytical perspective, the structure of an API is important because functional groups and molecular environments influence how the compound behaves during synthesis, storage, chromatographic separation, and mass spectrometric analysis.

Palbociclib also has pH-dependent solubility characteristics. According to the FDA prescribing information, its solubility is substantially higher at or below pH 4 and decreases above pH 4.

These characteristics matter when developing analytical procedures because sample preparation and mobile-phase conditions can influence chromatographic behavior and the appearance or measurement of related substances.

What Is Palbociclib Acetic Acid Adduct?

Palbociclib Acetic Acid Adduct is an identified compound associated with the palbociclib impurity profile. It has the CAS number 1974279-20-3, molecular formula C26H31N7O3, and molecular weight of approximately 489.58 g/mol according to Chemicea's product information.

It is important not to treat an impurity reference standard simply as another version of the API. A reference standard has a specific analytical purpose: it provides a known material against which an unknown peak or signal can be compared.

For laboratories working with palbociclib, having a dedicated reference material for the acetic acid adduct can therefore help with impurity identification, method development, system suitability work, and related-substance investigations.

The compound is also listed by other reference-standard suppliers under the same CAS number, supporting its identity as a recognized palbociclib-related impurity material.

Why an Acetic Acid Adduct Matters in Analytical Chemistry

The term “adduct” is particularly familiar to scientists working with mass spectrometry. In an analytical experiment, molecules can form non-covalent or chemically associated species with components present in the analytical environment. However, an isolated and characterized impurity described as an acetic acid adduct should not automatically be interpreted as merely an instrument-generated mass-spectrometric adduct.

This distinction is important.

An analytical signal observed during LC-MS may arise from ionization behavior, while an impurity present in a pharmaceutical sample represents an actual chemical species that requires appropriate characterization. Using an authentic reference material helps analysts distinguish between these possibilities.

For palbociclib impurity investigations, this can be especially useful when LC-MS or LC-HRMS is being used alongside chromatographic separation.

Recent research has demonstrated the value of LC-HRMS/MS for investigating palbociclib degradation products and elucidating their structures under forced-degradation conditions. One 2026 study reported identification of multiple degradation products involving oxidative, hydrolytic, and process-related pathways.

Where Can Palbociclib Acetic Acid Adduct Be Relevant?

The reference standard can have several analytical applications across pharmaceutical development.

1. Impurity Identification

When a chromatographic method shows an unknown peak in a palbociclib sample, analysts need to determine what that peak represents.

Comparison with an authentic Palbociclib Acetic Acid Adduct standard can provide an important identity reference. Retention behavior can be compared under the selected chromatographic conditions, while mass spectrometric data can provide additional confirmation.

This approach is considerably more reliable than assigning an impurity solely from a theoretical mass or database search.

2. Method Development

During development of an HPLC, UHPLC, or LC-MS method, impurity standards help analysts determine whether the analytical procedure can adequately separate the API from its related substances.

The objective is not simply to produce a chromatogram with multiple peaks. A useful method should provide adequate selectivity and reproducibility so that relevant impurities can be detected and quantified appropriately.

Published work on palbociclib has specifically investigated UHPLC methods for quantifying process-related impurities and evaluated characteristics such as specificity, accuracy, precision, linearity, and detection limits.

An authentic impurity standard can be particularly valuable during this type of method-development exercise.

3. Forced-Degradation Studies

Forced degradation is routinely used to understand how an API behaves under deliberately stressful conditions.

Samples may be exposed to conditions such as:

• Acidic environments

• Alkaline environments

• Oxidative conditions

• Elevated temperatures

• Light

• Other stress conditions relevant to the formulation or manufacturing process

The resulting samples are then examined for new chromatographic peaks and degradation products.

For palbociclib, recent LC-HRMS work has demonstrated how forced degradation combined with high-resolution mass spectrometry can help characterize degradation pathways.

If the analytical profile contains a peak corresponding to Palbociclib Acetic Acid Adduct, comparison with a qualified reference material can support the identification process.

4. Related-Substance Testing

Related-substance analysis is an important part of pharmaceutical quality control. The purpose is to monitor impurities and other related compounds at controlled levels rather than evaluating only the concentration of the main API.

A reference standard gives the laboratory a defined material for comparison and, where the analytical procedure supports it, quantitative work.

This becomes particularly important when an impurity has a known identity and needs to be distinguished from unidentified or unspecified peaks.

Palbociclib Acetic Acid Adduct and Regulatory Impurity Assessment

The regulatory significance of an impurity depends on factors such as its chemical identity, concentration, exposure, toxicological information, route of formation, and applicable regulatory requirements.

Interestingly, a recent European Medicines Agency assessment report for palbociclib Viatris discusses an acetic acid adduct as a potential process and degradation impurity. The report describes a proposed specification and notes that the impurity was considered in the context of ICH Q3B(R2) and mutagenicity assessment. The assessment also discusses computational evaluation under ICH M7.

This illustrates why impurity characterization is more than an academic exercise. Once an impurity is identified as potentially arising during pharmaceutical processing or degradation, its presence may need to be considered within the broader control strategy.

The exact regulatory treatment, however, depends on the specific product, manufacturing process, specification, dosage, exposure, and regulatory filing. Therefore, laboratories should rely on the applicable regulatory guidance and product-specific documentation rather than treating a single impurity classification as universally applicable.

Analytical Techniques Used for Characterization

No single analytical technique necessarily provides all the information required for impurity identification.

A combination of techniques may be used depending on the objective and available instrumentation.

HPLC and UHPLC

Reversed-phase HPLC remains one of the most widely used techniques for pharmaceutical related-substance analysis.

UHPLC can provide improved chromatographic efficiency and shorter analysis times when appropriately developed. Published research has described the development and validation of UHPLC methods for palbociclib and related impurities.

For an impurity reference standard, chromatographic behavior can be evaluated against the API and other known impurities.

LC-MS

Liquid chromatography coupled with mass spectrometry provides another layer of information.

After chromatographic separation, the mass-to-charge ratio of an impurity can be examined. This can help determine whether an observed peak is consistent with the expected molecular mass of the suspected compound.

However, mass information alone should not always be considered definitive structural proof. Ionization behavior, adduct formation, fragmentation, and matrix effects must be considered during interpretation.

LC-HRMS/MS

High-resolution mass spectrometry provides accurate-mass information and can be especially useful when investigating unknown degradation products.

MS/MS fragmentation can provide additional structural information by showing how a molecule breaks into characteristic fragments.

For palbociclib, recent research has used LC-HRMS/MS to investigate degradation products and support impurity identification.

Why Authentic Reference Standards Are Important

Suppose an analyst observes a peak that appears to have a mass consistent with Palbociclib Acetic Acid Adduct.

That observation creates a hypothesis, but it does not necessarily complete the identification.

An authentic reference standard allows the laboratory to compare the suspected impurity under controlled analytical conditions.

Depending on the analytical procedure, comparisons may include:

• Retention time

• UV response

• Molecular ion or accurate mass

• MS/MS fragmentation

• Chromatographic resolution

• Response characteristics

• Stability under the selected analytical conditions

This is one reason impurity reference standards are an important part of modern pharmaceutical analytical workflows.

Chemicea's product listing identifies Palbociclib Acetic Acid Adduct with CAT. No. CP-P65001, CAS No. 1974279-20-3, molecular formula C26H31N7O3, and molecular weight 489.58 g/mol.

Applications Across Pharmaceutical Development

The need for impurity standards can arise at different stages of pharmaceutical development rather than only during finished-product testing.

During process development, impurity standards can help chemists investigate compounds generated during synthesis.

During analytical method development, they can be used to establish chromatographic separation and evaluate method specificity.

During stability studies, reference standards can assist with investigating new peaks that appear as a product is stored under defined conditions.

During regulatory submissions, well-characterized impurity data can support the analytical sections of pharmaceutical development documentation.

And during quality-control testing, appropriate standards can support routine monitoring of specified related substances.

The same compound can therefore be relevant to different teams, including process chemists, analytical scientists, quality-control laboratories, formulation groups, and regulatory professionals.

Selecting a Palbociclib Impurity Reference Standard

Choosing an impurity standard should involve more than checking whether the compound name matches the target peak.

Laboratories should review the documentation supplied with the material and consider factors such as:

Identity: The compound should have clear identification information, including an appropriate chemical identifier such as CAS number where available.

Purity: The reported purity should be suitable for the intended analytical application.

Documentation: Relevant certificates and analytical documentation should be available for laboratory records and method-development activities.

Traceability: The source and characterization of the material should be documented.

Storage: Storage and handling instructions should be reviewed before use.

Application: A standard intended for analytical research should be selected according to the specific purpose of the laboratory study.

These checks become increasingly important when reference materials are used in regulated pharmaceutical environments.

Palbociclib Impurity Profiling: A Broader Perspective

Palbociclib does not have a single impurity pathway.

Chemicea's palbociclib portfolio includes the API along with multiple related materials, including process impurities, degradation-related compounds, nitrosamine-related standards, and other potential impurities.

This broader impurity profile reflects an important reality in pharmaceutical chemistry: impurity control is rarely about monitoring one compound in isolation.

Synthetic route, reaction conditions, purification, storage, formulation, and environmental exposure can all influence the final impurity profile. A well-designed analytical strategy therefore needs to consider the compounds that are reasonably expected to arise from the chemistry and the product's stability characteristics.

The Role of Chemicea in Pharmaceutical Reference Standards

For laboratories working on palbociclib analytical development, access to appropriately characterized reference materials can simplify impurity identification and method-development activities.

Chemicea focuses on pharmaceutical impurity reference standards and related analytical materials, including process impurities, degradation products, nitrosamines, metabolites, and other specialized reference compounds.

The Palbociclib Acetic Acid Adduct reference standard is part of this broader palbociclib impurity portfolio and can be considered for analytical research, impurity profiling, method development, and related pharmaceutical applications.

Frequently Asked Questions

What is Palbociclib Acetic Acid Adduct?

Palbociclib Acetic Acid Adduct is a palbociclib-related impurity reference material identified by CAS No. 1974279-20-3. It is used in analytical and pharmaceutical research applications where identification or monitoring of this specific compound is required.

What is the CAS number of Palbociclib Acetic Acid Adduct?

The CAS number is 1974279-20-3. Chemicea lists the compound under CAT. No. CP-P65001.

What is the molecular formula?

The molecular formula reported for Palbociclib Acetic Acid Adduct is C26H31N7O3, with a molecular weight of approximately 489.58 g/mol.

Why are impurity reference standards used?

Reference standards provide laboratories with characterized materials that can be compared with unknown or suspected impurity peaks. They are useful for analytical method development, impurity identification, forced-degradation investigations, and quality-control studies.

Can LC-MS be used to identify Palbociclib Acetic Acid Adduct?

LC-MS can provide useful molecular-mass information when investigating suspected impurities. LC-HRMS/MS can provide additional accurate-mass and fragmentation information. However, the analytical strategy should be selected according to the identification requirements and validated method.

Is Palbociclib Acetic Acid Adduct a process or degradation impurity?

An EMA assessment report describes the acetic acid adduct as a potential process and degradation impurity in its assessment of palbociclib. The actual formation pathway should be evaluated in the context of the specific manufacturing process and analytical data.

Conclusion

Palbociclib impurity analysis requires more than simply measuring the concentration of the API. Individual related substances need to be detected, separated, characterized, and, where appropriate, monitored using suitable analytical procedures.

Palbociclib Acetic Acid Adduct is one such compound of analytical interest. With its defined chemical identity and availability as a reference material, it can support laboratories investigating palbociclib-related substances through chromatographic and mass-spectrometric techniques.

As pharmaceutical analytical methods continue to become more sensitive and structurally informative, authentic impurity reference standards remain an important link between an observed analytical signal and a confidently characterized chemical entity. For laboratories developing or validating methods for palbociclib, a suitable reference standard can provide the practical comparison needed to turn an unidentified peak into useful analytical information.